Syngene International Limited (NSE:SYNGENE)
639.80
-2.55 (-0.40%)
At close: Dec 5, 2025
Syngene International Revenue
Syngene International had revenue of 9.11B INR in the quarter ending September 30, 2025, with 2.20% growth. This brings the company's revenue in the last twelve months to 37.47B, up 8.57% year-over-year. In the fiscal year ending March 31, 2025, Syngene International had annual revenue of 36.42B with 4.41% growth.
Revenue (ttm)
37.47B
Revenue Growth
+8.57%
P/S Ratio
6.80
Revenue / Employee
5.74M
Employees
6,533
Market Cap
254.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 36.42B | 1.54B | 4.41% |
| Mar 31, 2024 | 34.89B | 2.96B | 9.26% |
| Mar 31, 2023 | 31.93B | 5.89B | 22.61% |
| Mar 31, 2022 | 26.04B | 4.20B | 19.22% |
| Mar 31, 2021 | 21.84B | 1.72B | 8.57% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Mankind Pharma | 135.46B |
| Aurobindo Pharma | 325.14B |
| Fortis Healthcare | 84.37B |
Syngene International News
- 4 weeks ago - Syngene International Ltd (BOM:539268) Q2 2026 Earnings Call Highlights: Navigating Growth ... - GuruFocus
- 4 weeks ago - Q2 2026 Syngene International Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Goldman Sachs maintains buy on Syngene, bullish on FY26 early-teens growth outlook, sees 15.5% upside on Q1 beat and rising CRO-led margin gains - Business Upturn
- 4 months ago - Syngene Q1 profit up 59% to Rs 87 crore - The Times of India
- 4 months ago - Syngene International Q1 Results: Revenue grows 11% YoY to Rs 790 crore, Net profit jumps 59% YoY - Business Upturn
- 6 months ago - Syngene International receives EIR from USFDA for Biocon Park facility, inspection concludes with VAI classification - Business Upturn
- 8 months ago - Why are Syngene shares down 10% despite Q4 net profit jumping 2.8% YoY? - Business Upturn
- 8 months ago - Syngene International shares hit lower circuit crashing to 10% today after Q4 results - Business Upturn